Sleep Disorders Trial, Recruiting NCT06892158 Sponsor: Children's Hospital of Philadelphia Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06892158
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with cancer, such as acute myeloid leukemia (AML) or relapsed acute lymphoblastic leukemia (rALL), or who are admitted to receive a stem cell transplant (using either their own cells or a donor's cells) for any reason
  • People who are expected to stay in hospital for at least 21 days
  • People who are between 12 and 21 years old at the time of joining the trial
  • People who are currently admitted as inpatients at Children's National Hospital or Children's Hospital of Philadelphia (CHOP)

Who may not be able to join:

  • People with a level of cognitive (thinking or understanding) difficulty that would make it too hard to complete questionnaires appropriately
  • People who do not have enough knowledge of English or Spanish to complete the study materials
  • People who have already taken part in this trial before

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tracey Jubelirer, MD, Children's Hospital of Philadelphia

Phone: 267-426-1162

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Hospital of Philadelphia
Registry
ClinicalTrials.gov
Start date
23 January 2025
Est. completion
1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in total sleep minutes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov